Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06348745
NCT06348745Not yet recruitingNot Applicable

Trans Thoracic Ultrasound to Assess Diaphragmatic Function in Stable COPD Versus Bronchial Asthma.

Assiut University0 sites80 target enrollmentStarted: April 1, 2024Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
80
Primary Endpoint
diaphragmatic function
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

  • Assessment of diaphragmatic function (excursion, thickness variation, thickness ratio) in COPD and bronchial asthma patients.
  • Assessment of presence of correlation between diaphragmatic dysfunction and pulmonary function.
  • Assessment of possible association between diaphragmatic dysfunction and presence of reversibility in pulmonary function post bronchodilator.

Detailed Description

  • Assessment of diaphragmatic function (excursion, thickness variation, thickness ratio) in COPD and bronchial asthma patients.
  • Assessment of presence of correlation between diaphragmatic dysfunction and pulmonary function (FEV1/FVC).
  • Assessment of possible association between diaphragmatic dysfunction and presence of reversibility in pulmonary function post bronchodilator (short acting B2 agonist)

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Stable patients (not in exacerbation).

Exclusion Criteria

  • •Patients with comorbidities as cardiac, renal or hepatic diseases.
  • •Patients who have combined COPD and bronchial asthma.

Outcomes

Primary Outcomes

diaphragmatic function

Time Frame: 2 years

Compare diaphragmatic function using ultrasound device by measuring diaphragmatic thickness in both stable COPD and bronchial asthma patients.

Secondary Outcomes

  • pulmonary function .(2 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sara Amer

Doctor

Assiut University

Similar Trials

Completed
Not Applicable
Evaluation of Diaphragm in Chronic Obstructive Pulmonary Disease Patients by Ultrasound in Relation to SeverityChronic Obstructive Pulmonary Disease
NCT05035875Enas Sayed Farhat80
Not yet recruiting
Not Applicable
Prediction of Outcome of Non Invasive Ventilation COPD Patients by Assessment of Diaphragmatic PerformanceAcute Exacerbation COPD
NCT06143150Assiut University155
Completed
Not Applicable
Diaphragmatic Thickness and Pulmonary Function in Parkinson's DiseaseParkinson's Disease and Parkinsonism
NCT05194748Abant Izzet Baysal University37
Completed
Not Applicable
Ultrasound-Assessed Diaphragmatic Dysfunction as a Predictor of Weaning OutcomeWeaning FailureSepsis
NCT04825509Ain Shams University60
Recruiting
Not Applicable
Diaphragm Dysfunction and Ultrasound PerioperativelyRespiratory InsufficiencyDesaturation of BloodTachypneaAtelectasis, PostoperativePneumonia
NCT05906030Karolinska University Hospital160